Exagen Q3 EPS $(0.25) Misses $(0.18) Estimate, Sales $18.417M Beat $18.343M Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Exagen (NASDAQ:XGN) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.18) by 38.89 percent. This is a 31.58 percent decrease over losses of $(0.19) per share from the same
Exagen (NASDAQ:XGN) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.18) by 38.89 percent. This is a 31.58 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $18.417 million which beat the analyst consensus estimate of $18.343 million by 0.40 percent. This is a 6.80 percent increase over sales of $17.244 million the same period last year.